Manoj Mandal

Manoj Mandal

Auto-generated profile, based on publicly available information

Manoj Mandal

Department of Biochemistry and Molecular Biology, Gopalganj Science and Technology University, Gopalganj 8105, Bangladesh

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2025 in Journal of Chemistry Insights and Discoveries
Verified
Journal Article
Open access
PDF file
ABAitijjo Bhowmick
Aitijjo Bhowmick
KDKhokon Dutta
Khokon Dutta
RHRatan Hossain
Ratan Hossain
EHEsita Halder
Esita Halder
PBProbir Banjerjee
Probir Banjerjee
MMManoj Mandal
Manoj Mandal
Endoplasmic reticulum (ER) stress plays a critical role in the progression of type 2 diabetes mellitus (T2DM) through activation of the pro-apoptotic transcription factor C/EBP homologous protein (CHOP). Accumulation of CHOP in the nucleus promotes thioredoxin-interacting protein (TXNIP) expression and its translocation to mitochondria, thereby contributing to mitochondrial dysfunction and β-cell loss. Tauroursodeoxycholic acid (TUDCA) and ursodeoxycholic acid (UDCA) are established inhibitors of ER stress–induced CHOP expression. This study evaluated the combined effects of TUDCA and UDCA on body weight regulation and glycemic control in a rat model of T2DM induced by high-fat diet (HFD) feeding and low-dose streptozotocin (STZ). Swiss albino male rats were divided into four groups: control, HFD control, diabetic (HFD+STZ), and treatment [HFD+STZ+TUDCA (0.02%)/UDCA (0.3%)]. Body weight, fasting blood glucose, and postprandial blood glucose were assessed over 90 days. Supplementation with TUDCA and UDCA significantly reduced weight gain and improved glycemic control in diabetic rats (p < 0.0001). The incidence of diabetes was substantially lower in the treatment group compared with untreated diabetic rats, with 0% vs. 50% incidence by day 54 and 34% vs. 75% by day 90. By day 90, PBG levels were significantly lower in treated diabetic rats than in untreated diabetic rats (p < 0.0001). These findings indicate that combined TUDCA and UDCA supplementation exerts strong anti-obesogenic and anti-diabetic effects, enhancing glucose homeostasis and delaying diabetes onset. These findings suggest that blockers of TBP-2 mitochondrial shuttling, such as TUDCA and UDCA, may represent promising strategies for the prevention and treatment of T2DM.